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There is current “statin hysteria” with people prescribing statins for everything from STEMI to 
stroke to Alzheimer’s.  And the push is to give as much of the drug (high dose) and as early in 
the course (“ER”) as possible.  There is a reason why atorvastatin is one of the hottest selling 
drugs in the world. 
 
How much of this is “stuff we heard at a meeting” or worse “at a free dinner” – and how much is 
actually proven in good studies?  While I am not arguing about the use of statins for coronary 
stents, I do worry about the national recommendations to get a lipid level in the emergency 
department for patients with ST Elevation Myocardial Infarction (STEMI) and Acute Coronary 
Syndrome (ACS).  Why?  We do not know if the patient is fasting which can skew the measured 
LDL level significantly.  We know that periods of significant metabolic stress can affect the lipid 
levels.1  Then the most obvious question, what are you going to do with the level for the admitted 
patient who does not have ACS and does not receive a stent?  To which the makers of statins say 
“put them on a statin!” 
 
So here is the question.  In light of national groups asking for cholesterol and lipid panels in the 
emergency department for the possible ACS patient2, do we have any evidenced-based data that 
supports this recommendation?  Answer:  “No.” 
 
We do have data from 12 trials involving over 13,000 patients that proves that giving statins 
(compared to placebo) to patients with proven acute coronary syndromes as a whole does not 
reduce death, does not reduce nonfatal MI, and does not reduce nonfatal stroke, when one looks 
at the first four months after hospitalization for ACS.3  Furthermore, we have evidence that 
putting people on statins that do not have heart disease does not improve morbidity or mortality.4  
 
So forget the ER “lipid level” (it’s not accurate anyway) and say “no” to statins in the ER, at 
least until better data can prove to us otherwise. 
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